NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

European Commission presents a pharmaceutical strategy for Europe

By Irish Pharmacist - 05th Jan 2021

Creative concept photo of medical bottle with pills on pink background.

The European Commission has adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry.

The Strategy will allow Europe to cover its pharmaceutical needs, including in times of crisis, through robust supply chains. The Commission said the Strategy will help to establish a future-proof and crisis-resilient EU pharmaceutical system.

The flagship actions of the Strategy include:

  • A revision of the basic pharmaceutical legislation (target date for a proposal: 2022) with a view to making this framework future-proof and innovation friendly.
  • A proposal for an EU Health Emergency Response Authority (proposal: 2 semester 2021).
  • A revision of the regulations on medicines for children and rare diseases.
  • Initiating a structured dialogue with and between all actors in the pharmaceutical manufacturing and public authorities to identify vulnerabilities in the global supply chain of critical medicines and shape policy options to strengthen the continuity and security of supply in the EU.
  • Co-operation between national authorities on pricing, payment and procurement policies, to improve the affordability, cost-effectiveness of medicines and health systems’ sustainability.
  • The creation of a robust digital infrastructure, including a proposal for a European Health Data Space (target date for a proposal: 2021).
  • Support for research and innovation, notably via Horizon 2020 and EU4Health.
  • Actions to promote innovative approaches to EU R&D and public procurement for antimicrobials and their alternatives and measures to restrict and optimise their use.

President of the European Commission Ursula von der Leyen stated: “The coronavirus pandemic has highlighted the vital need to strengthen our health systems. This includes access to safe, effective and high-quality medicines at an affordable price. In the challenging economic and social times the EU is currently facing, the strategy adopted… will ensure that Europe and Europeans will continue to benefit from such medicines. I call on Member States and the Parliament to endorse this approach, which will be rolled out in the next three years and beyond.”

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist May 2024

Irish Pharmacist May 2024. Volume 25 | Issue 5 | May 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT